The Travelers Companies, Inc. (TRV) PT Raised to $150.00

The Travelers Companies, Inc. (NYSE:TRV) had its target price boosted by Citigroup Inc. from $140.00 to $150.00 in a research report issued to clients and investors on Thursday. The brokerage presently has a “buy” rating on the insurance provider’s stock. Citigroup Inc.’s target price points to a potential upside of 19.31% from the stock’s previous close.

Several other equities analysts have also issued reports on the company. BidaskClub lowered The Travelers Companies from a “buy” rating to a “hold” rating in a report on Wednesday, July 12th. Morgan Stanley reaffirmed an “underweight” rating and set a $119.00 price objective (up previously from $112.00) on shares of The Travelers Companies in a report on Friday, July 7th. Vetr raised The Travelers Companies from a “hold” rating to a “buy” rating and set a $132.68 price objective on the stock in a report on Monday, July 3rd. Keefe, Bruyette & Woods reaffirmed a “hold” rating on shares of The Travelers Companies in a report on Tuesday, June 20th. Finally, Bank of America Corporation lowered The Travelers Companies from a “buy” rating to a “neutral” rating and raised their price objective for the stock from $120.62 to $129.44 in a report on Monday, June 19th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $123.47.

Shares of The Travelers Companies (NYSE:TRV) opened at 125.72 on Thursday. The Travelers Companies has a 1-year low of $103.45 and a 1-year high of $129.60. The stock has a market cap of $35.13 billion, a P/E ratio of 12.37 and a beta of 1.20. The firm’s 50-day moving average price is $124.75 and its 200 day moving average price is $121.62.

This article was originally published by and is the sole property of Zolmax. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at https://zolmax.com/investing/the-travelers-companies-inc-trv-pt-raised-to-150-00/1524921.html

The Travelers Companies (NYSE:TRV) last issued its quarterly earnings data on Thursday, April 20th. The insurance provider reported $2.16 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.40 by $0.24. The firm had revenue of $6.18 billion for the quarter, compared to analysts’ expectations of $6.25 billion. The Travelers Companies had a return on equity of 12.01% and a net margin of 10.55%. The business’s revenue for the quarter was up 3.4% compared to the same quarter last year. During the same period in the previous year, the business posted $2.33 EPS. On average, equities analysts expect that The Travelers Companies will post $9.19 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, June 30th. Investors of record on Friday, June 9th were issued a dividend of $0.72 per share. The ex-dividend date of this dividend was Wednesday, June 7th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 2.29%. This is a positive change from The Travelers Companies’s previous quarterly dividend of $0.67. The Travelers Companies’s dividend payout ratio (DPR) is currently 28.40%.

ILLEGAL ACTIVITY NOTICE: This piece of content was reported by Zolmax and is the sole property of of Zolmax. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of United States and international copyright law. The correct version of this piece of content can be read at https://zolmax.com/investing/the-travelers-companies-inc-trv-pt-raised-to-150-00/1524921.html.

In other The Travelers Companies news, Vice Chairman William H. Heyman sold 7,000 shares of The Travelers Companies stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $123.48, for a total value of $864,360.00. Following the sale, the insider now owns 246,744 shares of the company’s stock, valued at approximately $30,467,949.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Vice Chairman Jay S. Benet sold 5,518 shares of The Travelers Companies stock in a transaction that occurred on Monday, July 10th. The shares were sold at an average price of $126.57, for a total value of $698,413.26. Following the completion of the sale, the insider now directly owns 82,824 shares in the company, valued at approximately $10,483,033.68. The disclosure for this sale can be found here. In the last three months, insiders have sold 184,746 shares of company stock worth $22,540,057. Corporate insiders own 0.82% of the company’s stock.

A number of large investors have recently made changes to their positions in the stock. Balasa Dinverno & Foltz LLC raised its stake in shares of The Travelers Companies by 0.3% in the first quarter. Balasa Dinverno & Foltz LLC now owns 3,448 shares of the insurance provider’s stock worth $416,000 after buying an additional 9 shares in the last quarter. American Economic Planning Group Inc. ADV raised its stake in shares of The Travelers Companies by 0.6% in the first quarter. American Economic Planning Group Inc. ADV now owns 2,529 shares of the insurance provider’s stock worth $305,000 after buying an additional 15 shares in the last quarter. Dubuque Bank & Trust Co. raised its stake in shares of The Travelers Companies by 0.6% in the first quarter. Dubuque Bank & Trust Co. now owns 3,970 shares of the insurance provider’s stock worth $479,000 after buying an additional 23 shares in the last quarter. Northern Oak Wealth Management Inc. raised its stake in shares of The Travelers Companies by 0.5% in the first quarter. Northern Oak Wealth Management Inc. now owns 4,873 shares of the insurance provider’s stock worth $587,000 after buying an additional 23 shares in the last quarter. Finally, Balentine LLC raised its stake in shares of The Travelers Companies by 2.0% in the first quarter. Balentine LLC now owns 1,404 shares of the insurance provider’s stock worth $169,000 after buying an additional 27 shares in the last quarter. 77.92% of the stock is currently owned by institutional investors.

The Travelers Companies Company Profile

The Travelers Companies, Inc is a holding company. The Company’s segments include Business and International Insurance; Bond & Specialty Insurance, and Personal Insurance. Through its subsidiaries, it provides commercial and personal property and casualty insurance products and services. The Business and International Insurance segment offers property and casualty insurance and insurance related services to its clients, in the United States and in Canada, as well as in the United Kingdom, the Republic of Ireland, Brazil and throughout other parts of the world.

Analyst Recommendations for The Travelers Companies (NYSE:TRV)

Receive News & Ratings for The Travelers Companies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Travelers Companies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

The Travelers Companies, Inc.  PT Raised to $150.00
The Travelers Companies, Inc. PT Raised to $150.00
Citigroup Inc. Lowers Jagged Peak Energy Inc.  Price Target to $18.00
Citigroup Inc. Lowers Jagged Peak Energy Inc. Price Target to $18.00
Spire Inc.  Stock Rating Lowered by Zacks Investment Research
Spire Inc. Stock Rating Lowered by Zacks Investment Research
Siemens AG  Rating Lowered to Sell at Zacks Investment Research
Siemens AG Rating Lowered to Sell at Zacks Investment Research
Polar Capital Holdings plc  Stock Rating Reaffirmed by Peel Hunt
Polar Capital Holdings plc Stock Rating Reaffirmed by Peel Hunt
BP plc  Stock Rating Reaffirmed by Goldman Sachs Group, Inc.
BP plc Stock Rating Reaffirmed by Goldman Sachs Group, Inc.


Leave a Reply

 
© 2006-2017 Zolmax.